PB1821 REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS INITIATED ON ANTI-CANCER THERAPIES IN THE UNITED STATES (US)
2019 ◽
Vol 3
(S1)
◽
pp. 834
X. Yang
◽
F. Laliberté
◽
G. Germain
◽
M. Raut
◽
M.S. Duh
◽
...
2019 ◽
Vol 3
(S1)
◽
pp. 829-830
X. Yang
◽
F. Laliberté
◽
G. Germain
◽
M. Raut
◽
M.S. Duh
◽
...
Xiaoqin Yang
◽
François Laliberté
◽
Guillaume Germain
◽
Monika Raut
◽
Mei Sheng Duh
◽
...
Xiaoqin Yang
◽
François Laliberté
◽
Guillaume Germain
◽
Monika Raut
◽
Mei Sheng Duh
◽
...
H. Yang
◽
Q. Ma
◽
X. Chai
◽
J. Zhang
◽
E.Q. Wu
◽
...
2019 ◽
Vol 3
(S1)
◽
pp. 113
X. Yang
◽
F. Laliberté
◽
G. Germain
◽
M. Raut
◽
M.S. Duh
◽
...
2014 ◽
Vol 89
(7)
◽
pp. 714-720
◽
Todd M. Gibson
◽
Eric A. Engels
◽
Christina A. Clarke
◽
Charles F. Lynch
◽
Dennis D. Weisenburger
◽
...
2012 ◽
Vol 21
(9)
◽
pp. 1520-1530
◽
Christopher R. Flowers
◽
Stacey A. Fedewa
◽
Amy Y. Chen
◽
Loretta J. Nastoupil
◽
Joseph Lipscomb
◽
...
2005 ◽
Vol 103
(8)
◽
pp. 1644-1651
◽
John C. Hornberger
◽
Jennie H. Best
J Garcia
◽
S Snyder
◽
M Gitlin
2021 ◽
Vol 19
(3.5)
◽
pp. EPR21-034
Wenzhen Ge
◽
Jon E. Arnason
◽
Ruben G.W. Quek
◽
Katie Keeven
◽
Knar Nersesyan
◽
...
Close
Export Citation Format
Close
Share Document
Close